Published in Proteomics Weekly, August 29th, 2005
Total revenues for the second quarter of 2005 were $6.9 million compared to $14.4 million in the second quarter of 2004. During the second quarter of 2005, the company recorded a net loss allocable to common stockholders of $5.8 million, or $0.41 per basic and diluted share, compared to a net income allocable to common stockholders of $1.6 million, or $0.11 per basic and diluted share, in the second quarter of 2004. Cash, cash equivalents, and short-term investments totaled approximately $35.7 million at June 30, 2005.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.